Dear Doctor - Participate in the Survey on breast cancer " The American Cancer Society’s most recent estimates for breast cancer in the United States are for 2018. In 2018, an estimated 266,120 new cases of invasive breast cancer will be diagnosed in women in the U.S. This includes 88060 cases of ductal carcinoma in situ (DCIS), which is a non-invasive form of breast cancer. Additionally, it is estimated that 63,960 women will die from breast cancer this year. However, death rates have been decreasing since 1989 due largely to improvements in screening and treatment advances. It is estimated that there are 3,410,000 women alive today who have been diagnosed with breast cancer at some point during their lives. Risk factors for developing breast cancer include: • being female and getting older – about two out of three invasive breast cancers are found in women who are 65 or older; • personal history of certain types of cancer – including ovarian cancer, ductal carcinoma in situ (DCIS), and lobular carcinoma in situ (LCIS); • family history of breast cancer – about 5 to 10% of invasive breast cancers are thought to be hereditary; • having dense breasts – denser breasts have more connective and glandular tissue than fatty tissue and can be more difficult to evaluate on a mammogram; • previous abnormal breast biopsy – an abnormal biopsy is one where atypical cells are found; Participate in Surveys "
1.
Retired Olympic athletes at greater risk of skin cancer and osteoarthritis, research reveals
2.
Three Cycles of Chemo Noninferior to Six for Rare Childhood Eye Cancer
3.
Celebrity Cancers Stoking Fear? Cisplatin Shortage Ends; Setback for Anti-TIGIT
4.
Year in Review: Non-Small Cell Lung Cancer
5.
Electronic Sepsis Alerts; Reducing Plaques in Coronary Arteries
1.
What Is Carboxyhemoglobin And How Can It Affect Your Health?
2.
Introducing the Corrected Calcium Calculator: A Revolutionary Tool in Medical Assessment
3.
Integrating Immunotherapy and Staging Guidelines in Lung Cancer Treatment
4.
The Technological Revolution in Precision Oncology and Tumor Microenvironment Therapy
5.
The Importance of Having a Quick and Effective Heparin Antidote
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
2.
Navigating the Complexities of Ph Negative ALL - Part XVI
3.
Benefits of Treatment with CDK4/6 Inhibitors in HR+/HER2- aBC in Clinical Trials and the Real World
4.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks
5.
Efficient Management of First line ALK-rearranged NSCLC - Part VII
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation